Details of the Drug Formulation (DFM)
| General Information of DFM (ID: F23832) | |||||
|---|---|---|---|---|---|
| Name |
Nafcillin 1g powder
|
||||
| Company |
Sagent Pharmaceuticals
|
||||
| Active Pharmaceutical Ingredient (API) | Nafcillin |
API Info
 click to show the detail info of this API
|
|||
| Approved | |||||
| Drug Inactive Ingredient (DIGs) | |||||
| DIG ID | DIG Info | DIG Name | DIG Functional Class | ||
| E0M5SQ | DIG Info | Sodium citrate anhydrous | Alkalizing agent ... | ||
| Full List of Biological Targets of DIG (DBTs) Regulated by DIG(s) in This DFM | ||||||
|---|---|---|---|---|---|---|
| Lyase/isomerase/ligase (L/I/G) | ||||||
| DBT Name: Carbonic anhydrase IV (CA4) | Click to Show/Hide | |||||
| Detailed Information |
DBT Info
click to show the detail info of this DBT
|
|||||
| Experiment for Assessing the Biological Activity of the Studied DIG on This DBT | ||||||
| Interacting DIG | Sodium citrate anhydrous | |||||
| Biological Activity | Ki = 99 nM (tested by experiment) | [1] | ||||
| Tested Species | Homo sapiens (Human) | |||||
| UniProt ID | CAH4_HUMAN | |||||
| References | |||||
|---|---|---|---|---|---|
| 1 | Carbonic anhydrase inhibitors. Interaction of isozymes I, II, IV, V, and IX with carboxylates. Bioorg Med Chem Lett. 2005 Feb 1; 15(3):573-8. | ||||
If you find any error in data or bug in web service, please kindly report it to Dr. Zhang and Dr. Mou.